🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

322 results for “Hospital Authority, Hong Kong” Clear

  1. Warfarin Sodium

    Hospital Authority, Hong Kong

    Indications for Warfarin Therapy

    phase 3 small molecule active

    1 trial

  2. cilostazol

    Hospital Authority, Hong Kong

    Coronary Artery Stenosis

    phase 3 small molecule active

    1 trial

  3. dydrogesterone

    Hospital Authority, Hong Kong

    Preterm Delivery

    phase 3 small molecule completed

    1 trial

  4. filgrastim

    Hospital Authority, Hong Kong

    Brain and Central Nervous System Tumors

    phase 3 mab completed

    2 trials

  5. individual lactation counseling and educational material

    Hospital Authority, Hong Kong

    Breastfeeding

    phase 3 other completed

    1 trial

  6. induced moderate hypothermia

    Hospital Authority, Hong Kong

    Traumatic Brain Injury

    phase 3 other terminated

    1 trial

  7. iron isomaltoside(Monofer®)

    Hospital Authority, Hong Kong

    Anemia, Iron-Deficiency

    phase 3 small molecule completed

    1 trial

  8. laser acupuncture

    Hospital Authority, Hong Kong

    Postpartum Weight Retention

    phase 3 other completed

    1 trial

  9. magnetic stimulation

    Hospital Authority, Hong Kong

    Neuropathic Pain

    phase 3 other completed

    1 trial

  10. one percent ultrasound power in CMICS

    Hospital Authority, Hong Kong

    Cataract

    phase 3 other active

    1 trial

  11. platelet-rich plasma combined with hyaluronic acid

    Hospital Authority, Hong Kong

    Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis)

    phase 3 other active

    1 trial

  12. robot-assisted surgery

    Hospital Authority, Hong Kong

    Rectal Cancer

    phase 3 other active

    1 trial

  13. total knee arthroplasty

    Hospital Authority, Hong Kong

    Osteoarthritis, Knee

    phase 3 mab active

    1 trial

  14. 12.5mg sunitinib with Cisplatin and Gemcitabine

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 2 small molecule completed

    1 trial

  15. 5% MInoxidil milky lotion

    Hospital Authority, Hong Kong

    Objective (Goal)

    phase 2 small molecule active

    1 trial

  16. 5-Fluorouracil

    Hospital Authority, Hong Kong

    Cancer (Advanced Stage)

    phase 2 small molecule active

    1 trial

  17. AS01 adjuvant (0.5 mL intramuscular)

    Hospital Authority, Hong Kong

    Immune System Responses and Trained Immunity After AS01 Administration

    phase 2 mab active

    1 trial

  18. ASLAN001

    Hospital Authority, Hong Kong

    Advanced/ Metastatic Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

  19. AZD9291

    Hospital Authority, Hong Kong

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule active

    1 trial

  20. Allogenic expanded Natural Killer Cells (AlloNK1)

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma (NPC)

    phase 2 mab active

    1 trial

  21. Apatinib

    Hospital Authority, Hong Kong

    Soft Tissue Sarcoma, Adult, Stage II

    phase 2 small molecule active

    1 trial

  22. Arm1

    Hospital Authority, Hong Kong

    Oral Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  23. Atorvastatin

    Hospital Authority, Hong Kong

    Vitiligo

    phase 2 small molecule completed

    1 trial

  24. Avatrombopag

    Hospital Authority, Hong Kong

    Chemotherapy-induced Thrombocytopenia

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources